Diagnostic Radiology and Nuclear Medicine
UMMC, Gudelski, C252
Education and Training
BM, Shanghai Medical University (now Fudan University), China
MPH, Shanghai Medical University (now Fudan University), China
PhD, University of Tokyo, Japan
Postdoc., Columbia University, NY
Internship in Internal Medicine, St. Peter's University Hospital, New Brunswick, NJ
Residency in Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
Fellowship in Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
I received my medical degree from China, and my Ph.D from Japan. I have more than a decade of basic science research experiences in molecular biology of lipid metabolism and atherosclerosis. After finishing my postdoctoral training at Columbia University, I restarted my clinical training, as a nuclear medicine resident and fellow, in the hospital of the University of Pennsylvania. I started my current position in 2009 as an assistant professor, and was promoted to associate professsor in 2014, and to full professor in 2019. I am a full-time board certified nuclear medicine physician, and provide services in general nuclear medicine imaging, PET/CT, and radionuclide therapy.
PET/CT, atherosclerosis, infection
Chen W, Dilsizian V. Diagnosis and Image-Guided Therapy of Cardiac Left Ventricular Assist Device Infections. Seminar Nuclear Medicine, 2020 Dec 3:S0001-2998 (20)30122-7
Chen W, Dilsizian V. Molecular Imaging of Amyloid Deposits in the Heart Allows Early Diagnosis of Cardiac Amyloidosis and the Potential for Monitoring Treatment Response. JACC Cardiovasc Imaging. 2020, Jun;13(6):1348-1352.
Chen W, Dilsizian V. Molecular Imaging of Cardiovascular Device Infection: Targeting the Bacteria or the Host-Pathogen Immune Response? J Nucl Med. 2020, March; 61(3):319-326.
Chen W, Dilsizian V. Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Questioning Standard Clinical Practice Requires Indisputable Scientific Data. J Nucl Med. 2019, Nov; 60(11):1502-1503
Chen W, Dilsizian V. Is 18F-Flurodeoxyglucose Positron Emission Tomography/Computed Tomography More Reliable than Clinical Standard Diagnosis for Guiding Patient Management Decisions in Cardiac Implantable Electronic Device Infection? Circ Cardiovasc Imaging. 2019, Jul;12(7):e009453.
Chen W , Jeudy J, Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR? Curr Cardiol Rep. 2019, Jun 26;21(8):76
Chen W, Dilsizian V. FDG PET/CT for the Diagnosis and Management of Infective Endocarditis: Expert Consensus versus Evidence-Based Practice. J Nucl Cardiol. 2019, Feb; 26(1):313-315.
Kim J, Feller ED, Chen W, Liang Y, Dilsizian V. FDG PET/CT for early detection and localization of left ventricular assist device infection: impact on patient management and outcome. JACC Cardiovasc Imaging. 2019, Apr. 12(4):722-729
Chen W, Sajadi M, Dilsizian V. Merits of FDG PET/CT and Functional Molecular Imaging over Anatomic Imaging with Echocardiography and CT angiography for the Diagnosis of Cardiac Device Infections. JACC Cardiovasc Imaging. 2018, Nov; 11(11):1679-1691.
New PET tracers for imaging atherosclerosis and infection
Nuclear Medicine and PET/CT
Provide services of General Nuclear Medicine imaging, PET/CT cancer imaging, Cardiac Stress Perfusion, and radionuclide therapy
including I-131 for thyroid disoeders, radioimunotherapy for non-Hodgkin’s lymphoma, radionuclides for bone pain
palliation and Xofigo (Radium-223) for prostate cancer bone metastases.
Travel Grant Award, 34th ACNM annual meeting
Honorable Mention of the Siemens Award for Excellence in Practice Based Research, 55th SNMMI annual meeting
Teaching Award, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine
Science Council Research Symposium Oral Presentation and the Best in Physics Poster, American Association of Physicists in Medicine Annual Meeting
First Place Poster - Clinical Diagnosis Track, 59th SNMMI Annual Meeting
Elite Reviewer, JACC, Journal of the American College of Cardiology
Third Place Poster - Oncology: Clinical Diagnosis Track, 60th SNMMI Annual Meeting
SNMMI Future Leaders Academy
FACNM, fellow of American College of Nuclear Medicine
Presidential Distinguished Service Award, SNMMI
08/01/2013-07/31/2020 Co-Inv (2% effort), PI: Dr. Mark Smith “Brain Imaging Device with Motion Compensation” Maryland Industrial Partnerships Program, MIPS 5201
08/19/2016-07/30/2021 Co-Inv (5% effort), PI: Dr. Amit Sawant “Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung Stereotactic Ablative Body Radiotherapy (SAbR)”, R01CA172638, NIH/NCI
07/01/2013-06/30/2017, Co-Investigator (6.4% effort), R01CA172638, NIH/NCI, (PI: Dr. Wei Lu, Department of Radiation Oncology, UMB), Quantitative PET/CT Analysis to Improve Evaluation of Tumor Response
09/01/2012-08/30/2013 Principal Investigator ,UMB/UMD seed fund, 18F-Proline PET/CT Imaging for the Detection of Early Liver Fibrosis
07/01/2007-06/30/2008 Principal Investigator, Pilot Research Grant in Molecular Imaging, SNMMI, Glucose metabolism in macrophage foam cells: Molecular mechanism for FDG-PET imaging of atherosclerosis
Top Doctor in Nuclear Medicine, Baltimore Magazine, 2020
2011-present Editorial Board, Clinical Nuclear Medicine
2011-present Abstract Review Panel (Endocrinology and Neuroendocrine tumor sections), SNMMI Annual Meeting
2014-present Committee Member, Membership Task Force, SNMMI
2014-present Executive Committee, Mid-Eastern Chapter, SNMMI
2015-present Editorial Board, Applied Radiology
2015-2020 Board of Directors, Cardiovascular Council, SNMMI
2018-2020 Secretary, Cardiovascular Council, SNMMI
2016-2018 Treasure, Mid-Eastern Chapter, SNMMI
2018-2020 Vice President, Mid-Eastern Chapter, SNMMI
2017-present Board of Directors, American Board of Nuclear Medicine (ABNM)
2017-present Chair, Cardiovascular Section, American Board of Nuclear Medicine (ABNM)
2020-present President-elected, Mid-Eastern Chapter, SNMMI
2018-present Co-Chair, Committee Member, Membership Task Force, SNMMI